Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity-Reference-Cited by-同舟云学术

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity

Published:2017-05-19 Issue:43 Volume:8 Page:73925-73937
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dohmen Amy J.C.¹,Qiao Xiaohang²,Duursma Anja²,Wijdeven Ruud H.²,Lieftink Cor³,Hageman Floor⁴,Morris Ben³,Halonen Pasi³,Vens Conchita⁴,van den Brekel Michiel W.M.¹⁵,Ovaa Huib²⁶,Neefjes Jacques²⁶,Zuur Charlotte L.¹⁵

Affiliation:

1. Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

2. Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

3. NKI Robotics and Screening Center, The Netherlands Cancer Institute, Amsterdam, The Netherlands

4. Division of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands

5. Department of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

6. Department of Chemical Immunology, Leiden University Medical Center, Leiden, The Netherlands

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of ATM inhibitors: Opportunities and challenges;European Journal of Medicinal Chemistry;2024-11

2. Recent advancement of analytical approaches for assessing Ataxia telangiectasia mutated kinase inhibitors in Ataxia telangiectasia: An overview;Process Biochemistry;2024-09

3. Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective;Journal of Medicinal Chemistry;2024-08-16

4. Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation;Cell Death Discovery;2024-06-12

5. Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma;Clinical and Translational Radiation Oncology;2024-01